Germany’s ITM receives material license to produce Lu-177
January 9, 2024, 12:01PMNuclear News
Bavarian minister of state Florian Herrmann (left) with ITM CEO Steffen Schuster (right) and others at a mock-up Lu-177 hot cell. (Photo: ITM)
Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the company’s NOVA facility in Neufahrn, near Munich, Germany.
To continue reading, log in or create a free account!
Tags:
Share: